These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 30989372)
21. Parkinson's disease and periodontitis - the missing link? A review. Kaur T; Uppoor A; Naik D Gerodontology; 2016 Dec; 33(4):434-438. PubMed ID: 25664991 [TBL] [Abstract][Full Text] [Related]
22. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease. Nexoe AB; Pilecki B; Von Huth S; Husby S; Pedersen AA; Detlefsen S; Marcussen N; Moeller JB; Holmskov U; Sorensen GL Inflamm Bowel Dis; 2019 Jul; 25(8):1349-1356. PubMed ID: 30753482 [TBL] [Abstract][Full Text] [Related]
23. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group]. Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977 [TBL] [Abstract][Full Text] [Related]
24. Migraine in multiple sclerosis and other chronic inflammatory diseases. Moisset X; Giraud P; Dallel R Rev Neurol (Paris); 2021 Sep; 177(7):816-820. PubMed ID: 34325914 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of inflammatory bowel disease. Whelan G Med Clin North Am; 1990 Jan; 74(1):1-12. PubMed ID: 2404170 [TBL] [Abstract][Full Text] [Related]
26. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota. Dobbs SM; Dobbs RJ; Weller C; Charlett A; Augustin A; Taylor D; Ibrahim MA; Bjarnason I J Neurovirol; 2016 Feb; 22(1):22-32. PubMed ID: 26092111 [TBL] [Abstract][Full Text] [Related]
27. Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease. Coates MD; Ba DM; Liu G; Dalessio S; Leslie DL; Huang X Inflamm Bowel Dis; 2022 Jun; 28(6):850-854. PubMed ID: 34259840 [TBL] [Abstract][Full Text] [Related]
28. Epidemiological evolution of epidemiology of the inflammatory bowel diseases in a hospital of Tunis. Ouakaa-Kchaou A; Gargouri D; Bibani N; Elloumi H; Kochlef A; Kharrat J Tunis Med; 2013 Jan; 91(1):70-3. PubMed ID: 23404603 [TBL] [Abstract][Full Text] [Related]
29. Challenges and progress in pediatric inflammatory bowel disease. Rufo PA; Bousvaros A Curr Opin Gastroenterol; 2007 Jul; 23(4):406-12. PubMed ID: 17545777 [TBL] [Abstract][Full Text] [Related]
30. Genetics of inflammatory bowel disease. Satsangi J; Parkes M; Jewell DP; Bell JI Clin Sci (Lond); 1998 May; 94(5):473-8. PubMed ID: 9682668 [TBL] [Abstract][Full Text] [Related]
31. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705 [TBL] [Abstract][Full Text] [Related]
32. LRRK2 and the Immune System. Dzamko NL Adv Neurobiol; 2017; 14():123-143. PubMed ID: 28353282 [TBL] [Abstract][Full Text] [Related]
33. Upregulation of enteric alpha-synuclein as a possible link between inflammatory bowel disease and Parkinson's disease. Derkinderen P; Noble W; Neunlist M; Rolli-Derkinderen M Gut; 2021 Oct; 70(10):2010-2012. PubMed ID: 33203725 [No Abstract] [Full Text] [Related]
34. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease. Campos-Acuña J; Elgueta D; Pacheco R Front Immunol; 2019; 10():239. PubMed ID: 30828335 [TBL] [Abstract][Full Text] [Related]
35. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity. Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920 [TBL] [Abstract][Full Text] [Related]
36. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118 [TBL] [Abstract][Full Text] [Related]
37. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450 [TBL] [Abstract][Full Text] [Related]
38. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976 [TBL] [Abstract][Full Text] [Related]